Roche drug helped breast cancer patients survive longer Reuters | ZURICH (Reuters) - Swiss drugmaker Roche Holding AG said its "armed antibody" T-DM1 drug significantly extended the lives of women with an aggressive type of breast cancer compared to those receiving the standard drug cocktail.
0 comments:
Post a Comment